Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial

@article{Schmidt2017TreatmentWL,
  title={Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial},
  author={S. Schmidt and V. Gocheva and T. Zumbrunn and D. Rubino-Nacht and U. Bonati and D. Fischer and P. Hafner},
  journal={Trials},
  year={2017},
  volume={18}
}
BackgroundPost-polio syndrome (PPS) is a condition that affects polio survivors years after recovery from an initial acute infection by the Poliomyelitis virus. [...] Key Method This investigator-initiated, randomised, placebo-controlled, double-blind, trial aims to demonstrate that L-citrulline positively influences muscle function and increases muscular energy production in patients with PPS.Methods/designThirty ambulant PPS patients will be recruited in Switzerland.Expand

References

SHOWING 1-10 OF 36 REFERENCES
Treatment for postpolio syndrome.
Pathogenetic Mechanisms of Post‐Polio Syndrome: Morphological, Electrophysiological, Virological, and Immunological Correlations
  • M. Dalakas
  • Biology, Medicine
  • Annals of the New York Academy of Sciences
  • 1995
Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors
Citrulline modulates muscle protein metabolism in old malnourished rats.
Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.
Poliomyelitis and the postpolio syndrome
  • R. Howard
  • Medicine
  • BMJ : British Medical Journal
  • 2005
Quantitative MRI can detect subclinical disease progression in muscular dystrophy
...
1
2
3
4
...